SPY402.35+0.63 0.16%
DIA324.37+2.14 0.66%
IXIC11,742.92-62.09 -0.53%

--Guggenheim Adjusts Price Target on Bristol-Myers Squibb to $80 From $72, Reiterates Buy Rating

MT Newswires · 05/02/2022 03:29

Please log in to view news